Rivkin SE - Search Results

1

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.

Ravdin PM, Green S, Dorr TM, McGuire WL, Fabian C, Pugh RP, Carter RD, Rivkin SE, Borst JR, Belt RJ, et al. Ravdin PM, et al. Among authors: rivkin se. J Clin Oncol. 1992 Aug;10(8):1284-91. doi: 10.1200/JCO.1992.10.8.1284. J Clin Oncol. 1992. PMID: 1634918

2

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study.

Elledge RM, Green S, Howes L, Clark GM, Berardo M, Allred DC, Pugh R, Ciocca D, Ravdin P, O'Sullivan J, Rivkin S, Martino S, Osborne CK. Elledge RM, et al. J Clin Oncol. 1997 May;15(5):1916-22. doi: 10.1200/JCO.1997.15.5.1916. J Clin Oncol. 1997. PMID: 9164202

3

Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.

Hutchins LF, Green SJ, Ravdin PM, Lew D, Martino S, Abeloff M, Lyss AP, Allred C, Rivkin SE, Osborne CK. Hutchins LF, et al. Among authors: rivkin se. J Clin Oncol. 2005 Nov 20;23(33):8313-21. doi: 10.1200/JCO.2005.08.071. J Clin Oncol. 2005. PMID: 16293862 Clinical Trial.

4

Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.

Rivkin SE, Green S, Metch B, Glucksberg H, Gad-el-Mawla N, Constanzi JJ, Hoogstraten B, Athens J, Maloney T, Osborne CK, et al. Rivkin SE, et al. J Clin Oncol. 1989 Sep;7(9):1229-38. doi: 10.1200/JCO.1989.7.9.1229. J Clin Oncol. 1989. PMID: 2671283 Clinical Trial.

5

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.

Rivkin SE, Green S, Metch B, Cruz AB, Abeloff MD, Jewell WR, Costanzi JJ, Farrar WB, Minton JP, Osborne CK. Rivkin SE, et al. J Clin Oncol. 1994 Oct;12(10):2078-85. doi: 10.1200/JCO.1994.12.10.2078. J Clin Oncol. 1994. PMID: 7931477 Clinical Trial.

6

One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.

Rivkin SE, Green S, Metch B, Jewell WR, Costanzi JJ, Altman SJ, Minton JP, O'Bryan RM, Osborne CK. Rivkin SE, et al. J Clin Oncol. 1993 Sep;11(9):1710-6. doi: 10.1200/JCO.1993.11.9.1710. J Clin Oncol. 1993. PMID: 8355037 Clinical Trial.

7

Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.

Rivkin SE, Green S, O'Sullivan J, Cruz AB, Abeloff MD, Jewell WR, Costanzi JJ, Farrar WB, Osborne CK. Rivkin SE, et al. J Clin Oncol. 1996 Jan;14(1):46-51. doi: 10.1200/JCO.1996.14.1.46. J Clin Oncol. 1996. PMID: 8558219 Clinical Trial.

8

Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: a Southwest Oncology Group Study.

Alberts DS, Mason NL, O'Toole RV, Hilgers RD, Rivkin SE, Boutselis JG, Pugh RP, Vaitkevicius VK, Green JB, Oishi N. Alberts DS, et al. Among authors: rivkin se. Gynecol Oncol. 1987 Feb;26(2):193-201. doi: 10.1016/0090-8258(87)90273-3. Gynecol Oncol. 1987. PMID: 3542743 Clinical Trial.

9

Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study.

Albain KS, Green S, LeBlanc M, Rivkin S, O'Sullivan J, Osborne CK. Albain KS, et al. Breast Cancer Res Treat. 1992;22(3):273-84. doi: 10.1007/BF01840840. Breast Cancer Res Treat. 1992. PMID: 1391993

10

Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status.

Rivkin SE, Knight WA 3rd, McDivitt R, Cruz T, Foulkes M, Osborne CK, Fabian CJ, Costanzi JJ. Rivkin SE, et al. J Steroid Biochem. 1985 Dec;23(6B):1151-4. doi: 10.1016/0022-4731(85)90035-4. J Steroid Biochem. 1985. PMID: 3912621 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page